Get the Stockscreener App
10.03
8.43%
0.78
After Hours:
10.03
Xencor Inc stock is traded at $10.03, with a volume of 1.81M.
It is up +8.43% in the last 24 hours and up +28.43% over the past month.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
See More
Previous Close:
$9.25
Open:
$9.48
24h Volume:
1.81M
Relative Volume:
2.37
Market Cap:
$715.37M
Revenue:
$133.62M
Net Income/Loss:
$-177.37M
P/E Ratio:
-3.4706
EPS:
-2.89
Net Cash Flow:
$23.50M
1W Performance:
+18.00%
1M Performance:
+28.43%
6M Performance:
-20.52%
1Y Performance:
-51.89%
1-Day Range:
$9.45
$10.17
1-Week Range:
$8.26
$10.17
52-Week Range:
$6.92
$27.24
Xencor Inc Stock (XNCR) Company Profile
Name
Xencor Inc
Sector
Industry
Phone
626-305-5900
Address
465 N. HALSTEAD ST., PASADENA, CA
Compare XNCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
10.03 | 659.74M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-21-25 | Initiated | William Blair | Outperform |
| Dec-12-24 | Initiated | Wells Fargo | Overweight |
| Dec-02-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-16-24 | Reiterated | BTIG Research | Buy |
| Feb-28-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-19-23 | Initiated | BofA Securities | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Oct-13-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Jul-06-22 | Resumed | Canaccord Genuity | Buy |
| Feb-11-22 | Initiated | BMO Capital Markets | Outperform |
| Jan-21-22 | Initiated | SMBC Nikko | Outperform |
| Dec-15-21 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Feb-24-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-04-20 | Initiated | Barclays | Underweight |
| Feb-25-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-30-20 | Initiated | RBC Capital Mkts | Outperform |
| Nov-20-19 | Resumed | Guggenheim | Neutral |
| Aug-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-13-19 | Initiated | Mizuho | Buy |
| Apr-12-19 | Initiated | Guggenheim | Buy |
| Mar-27-19 | Initiated | Berenberg | Buy |
| Mar-15-19 | Initiated | Raymond James | Outperform |
| Sep-10-18 | Resumed | BTIG Research | Buy |
| Mar-28-18 | Resumed | Leerink Partners | Outperform |
| Mar-02-17 | Initiated | Instinet | Neutral |
| Mar-02-17 | Reiterated | Wedbush | Outperform |
| Oct-04-16 | Initiated | Piper Jaffray | Overweight |
| Dec-22-15 | Initiated | Canaccord Genuity | Buy |
| Aug-05-15 | Reiterated | MLV & Co | Buy |
| Feb-12-15 | Reiterated | Oppenheimer | Outperform |
| Jan-28-15 | Reiterated | MLV & Co | Buy |
| Jul-11-14 | Initiated | Oppenheimer | Outperform |
View All
Xencor Inc Stock (XNCR) Latest News
Xencor (NASDAQ:XNCR) Trading Up 5.4%Time to Buy? - MarketBeat
Risk Analysis: Is Xencor Inc impacted by rising ratesWeekly Profit Report & Capital Efficient Trade Techniques - خودرو بانک
Strength Seen in Xencor (XNCR): Can Its 7.3% Jump Turn into More Strength? - Yahoo Finance
Aug Action: Can Xencor Inc. withstand a market correctionJuly 2025 Volume & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Xencor (NASDAQ:XNCR) Earns Underweight Rating from Analysts at Barclays - MarketBeat
Is Xencor (NASDAQ:XNCR) Weighed On By Its Debt Load? - 富途牛牛
Fundamentals Check: Is Xencor Inc stock a good pick for beginners2025 Technical Patterns & Smart Swing Trading Techniques - خودرو بانک
Aug Sentiment: Can Xencor Inc. disrupt its industryTreasury Yields & Free Community Supported Trade Ideas - خودرو بانک
Xencor’s SWOT analysis: biotech firm’s stock faces mixed outlook - Investing.com
Decliners Report: Is Xencor Inc backed by strong institutional buyingWatch List & Consistent Income Trade Ideas - خودرو بانک
Barclays initiates Xencor stock with Underweight rating on pipeline concerns By Investing.com - Investing.com Nigeria
Barclays initiates Xencor stock with Underweight rating on pipeline concerns - Investing.com
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Rally Mode: How does Xencor Inc. correlate with NasdaqAnalyst Upgrade & Weekly Momentum Picks - خودرو بانک
Insider Buy: Will Xencor Inc stock hit new highs in YEARJuly 2025 Analyst Calls & Capital Efficiency Focused Ideas - خودرو بانک
US Market Wrap: Is Xencor Inc. a potential multi baggerWeekly Stock Summary & Low Drawdown Momentum Ideas - خودرو بانک
Smart Money: Will Herbalife Ltd. benefit from rising consumer demandEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Retail Trends: Does C.H. Robinson Worldwide Inc. meet Warren Buffett’s criteria2025 Big Picture & Fast Moving Stock Watchlists - خودرو بانک
Trading Recap: Will Xencor Inc stock hit new highs in YEARJuly 2025 Institutional & Stepwise Entry/Exit Trade Alerts - خودرو بانک
Xencor, Inc. $XNCR Shares Bought by Goldman Sachs Group Inc. - MarketBeat
Recap Report: Can Xencor Inc stock outperform in a bear market2025 Investor Takeaways & Free High Accuracy Swing Entry Alerts - خودرو بانک
Buybacks Report: What is the target price for Xencor Inc stockWeekly Trend Recap & Long-Term Growth Stock Strategies - خودرو بانک
Hedge Fund Moves: What hedge funds are buying Xencor IncPortfolio Value Report & Fast Entry Momentum Alerts - خودرو بانک
Sell Signal: How do insiders feel about Xencor IncQuarterly Profit Summary & Low Risk Entry Point Guides - خودرو بانک
Treasury Yields: Will Xencor Inc stock go up in YEARShare Buyback & Target Return Focused Picks - خودرو بانک
Support Test: Will Xencor Inc. announce a stock splitPortfolio Growth Summary & Free Safe Entry Trade Signal Reports - خودرو بانک
Valuation Update: How volatile is Xencor Inc stockJuly 2025 Macro Moves & Trade Opportunity Analysis - خودرو بانک
Sector ETF performance correlation with Xencor Inc.Market Risk Report & Fast Moving Stock Watchlists - newser.com
Analyzing drawdowns of Xencor Inc. with statistical toolsMarket Activity Report & Fast Exit Strategy with Risk Control - newser.com
Is now a turning point for Xencor Inc.Weekly Loss Report & Consistent Return Strategy Ideas - newser.com
What recovery options are there for Xencor Inc.Trade Exit Report & Weekly High Conviction Trade Ideas - newser.com
What to do if you’re stuck in Xencor Inc.July 2025 Short Interest & High Conviction Trade Alerts - newser.com
Will Xencor Inc. outperform the marketJuly 2025 Chart Watch & Momentum Based Trading Ideas - newser.com
Xencor’s Clinical Milestones Set to Define Biotech Investment Case - AD HOC NEWS
Will Xencor Inc. continue its uptrendJuly 2025 WrapUp & Fast Gain Swing Alerts - newser.com
Xencor, Inc. $XNCR Position Increased by Jacobs Levy Equity Management Inc. - MarketBeat
Cubist Systematic Strategies LLC Acquires Shares of 155,580 Xencor, Inc. $XNCR - MarketBeat
RBC Cuts Xencor (XNCR) Price Target but Keeps Outperform Rating - MSN
Trexquant Investment LP Has $1.42 Million Position in Xencor, Inc. $XNCR - MarketBeat
Automated trading signals detected on Xencor Inc.Quarterly Earnings Summary & Short-Term High Return Strategies - Newser
Real time social sentiment graph for Xencor Inc.Portfolio Value Summary & Consistent Income Trade Recommendations - Newser
Xencor Inc. stock outlook for YEARWeekly Trade Review & Community Consensus Stock Picks - Newser
BofA Securities Downgrades Xencor(XNCR.US) to Hold Rating, Cuts Target Price to $12 - 富途牛牛
AI Indicators Detect Buy Opportunity in Xencor Inc.July 2025 Action & High Return Trade Opportunity Guides - beatles.ru
Xencor (NASDAQ:XNCR) Downgraded to Neutral Rating by Bank of America - MarketBeat
Top 10 Stocks Under $10 That Could Triple - Insider Monkey
Xencor (NASDAQ:XNCR) Given "Outperform" Rating at Wedbush - MarketBeat
Xencor Inc. At Critical Juncture — Bounce or Breakdown2025 Analyst Calls & Free Real-Time Volume Trigger Notifications - beatles.ru
Xencor (NASDAQ:XNCR) Stock Price Up 6%Still a Buy? - MarketBeat
ADAR1 Capital Management LLC Boosts Stock Holdings in Xencor, Inc. $XNCR - MarketBeat
Xencor Inc. stock trend outlook and recovery pathMarket Risk Analysis & Growth Oriented Trade Recommendations - Newser
Xencor Inc Stock (XNCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):